A note on the relapse rate over a four-year period in patients with quiescent pulmonary tuberculosis following treatment with reserve regimens.
D003523:Cycloserine / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D011718:Pyrazinamide / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide; D013307:Streptomycin